An Albuquerque family, fought against all odds to ensure their baby's survival after a rare diagnosis, that effects about ...

A study by Nagoya University Graduate School of Medicine in Japan suggests the importance of tailored exercise programs for ...

Weak: only small or nonrandomized trials available; Unknown: not enough data to determine benefit. ERA: Endothelin receptor antagonist; PDE5: Phosphodiesterase type 5; PH: Pulmonary hypertension.

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy ...

Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary artery denervation (PADN) as an innovative intervention for ...

Objective Whether splenectomy increases the risk of chronic thromboembolic pulmonary hypertension (CTEPH) remains unclear. We conducted a systematic review and meta-analysis to explore the association ...

Read at the Annual Meeting of the New England Surgical Society, Burlington, Vermont, September 29, 1934. Truesdale, Philemon E. — Surgeon, Fall River, Mass. Phippen ...

Aaron Holley, MD, writes that it takes a 'physiologic village' to create activity intolerance after pulmonary embolism, and argues for more use of cardiopulmonary exercise testing to evaluate it.

Background: Pulmonary arterial hypertension (PAH) is an incurable pulmonary disease that might result in right heart failure and death. Treatment guidelines recommend upfront or sequential combination ...